Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Agreement supports Arkema’s project to modernize access to R&D data and reduce design times for new products.
April 15, 2021
By: Charlie Sternberg
Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, has been selected by Arkema, a leader in speciality materials, as its informatics partner in an R&D digitalization project. Implementing Dotmatics’ unified electronic laboratory notebook (ELN) across Arkema’s research sites in France, the agreement covers 800 users and will run over five years. At a time when the Chemical Industry is transforming R&D through digitalizing laboratory workflows, the agreement supports Arkema’s project to modernize access to R&D data and reduce design times for new products. The objective is to ensure digital continuity of all experimental data, thus allowing for faster innovation of chemicals and materials driven by statistics, calculation and modelling, and artificial intelligence. Dotmatics will equip Arkema scientists with a complete ELN solution including experiment capture, entity registration and sample tracking, data retrieval, and full data analytics. The unified platform will accommodate the diversity of Arkema’s workflow across synthetic chemistry, formulation and polymers allowing researchers to trace, share, secure and exploit all their R&D data internally and will facilitate collaboration with external partners. Steve Gallagher, CEO of Dotmatics, commented, “With our shared spirit of collaboration, we are delighted to have been chosen as a partner to implement their R&D digitalization project and we welcome Arkema to the Dotmatics community of global scientific organizations.” He continued, “Implementing Dotmatics’ ELN will allow Arkema researchers to leverage valuable corporate R&D data. Web-based rapid capture, search and retrieval of data combined with advanced analytics will support global shared decision-making: empowering scientists to innovate.” Gérard Guilpain, scientific director of digitalization of R&D at Arkema, commented, “The ELN is a fundamental digital building block for processing experimental results generated in our laboratories. We are happy to have selected Dotmatics, which will allow us to modernize our work approaches and use a cloud infrastructure as a space for digital continuity to gain value more rapidly from the Group’s research data.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !